News | 09.01.20
CMS Proposed Rule Seeks to Accelerate Coverage and Access for FDA’s Designated Breakthrough Devices
September 1, 2020—The Centers for Medicare & Medicaid Services (CMS) announced it has issued a proposed rule named Medicare Coverage of Innovative Technology (MCIT) (CMS-3372-P), which is intended to allow Medicare beneficiaries to have faster access to the innovative technology.
News | 08.27.20
ACC’s MedAxiom 2020 Compensation and Production Survey Includes New PCI Measures
August 27, 2020—MedAxiom, an American College of Cardiology company focused on cardiovascular organizational performance solutions, has released its eighth annual Cardiovascular Provider Compensation and Production Survey.
News | 08.05.20
SCAI Seeks to Challenge Reductions in Proposed CMS Payment Schedule
August 5, 2020—The Society for Cardiovascular Angiography & Interventions (SCAI) announced that the Centers for Medicare & Medicaid Services (CMS) is proposing a shift in payments from procedures and to evaluation and management services for 2021.
News | 10.31.19
CMS 2020 Final Hospital Outpatient Rule Allows Reimbursement of PCI in Ambulatory Centers
November 1, 2019—The American College of Cardiology (ACC) announced that the Centers for Medicare and Medicaid Services (CMS) will release the 2020 Medicare Physician Fee Schedule final rule addressing Medicare payment and quality provisions for physicians in 2020, under which, physicians will see a virtually flat conversion factor on January 1, 2020, going from $36.04 to $36.09.
Article | September/October 2019
News | 07.29.19
CMS Releases Proposed 2020 Medicare Physician Fee Schedule and Hospital Outpatient Rules
July 29, 2019—The American College of Cardiology (ACC) announced that the Centers for Medicare & Medicaid Services (CMS) released the proposed 2020 Medicare Physician Fee Schedule and the proposed 2020 Hospital Outpatient Prospective Payment System rule.
News | 06.26.19
SCAI Supports CMS Decision Memo on Procedural Requirements for TAVR
June 27, 2019—The Society for Cardiovascular Angiography and Interventions (SCAI) released a statement regarding the Centers for Medicare & Medicaid Services (CMS) finalized Decision Memo on Transcatheter Aortic Valve Replacement (TAVR) released on June 21.
News | 06.23.19
Medtronic and Edwards Issue Statements Supporting the CMS National Coverage Determination for TAVR
June 21, 2019—Medtronic plc and Edwards Lifesciences Corporation separately issued statements regarding the Centers for Medicare & Medicaid Services (CMS) final decision memo updating the transcatheter aortic valve replacement (TAVR) national coverage determination (NCD).
News | 06.20.19
CMS Issues National Coverage Decision Updating Policy for TAVR
June 21, 2019—The Centers for Medicare & Medicaid Services (CMS) announced it will continue to cover transcatheter aortic valve replacement (TAVR) under coverage with evidence development (CED) when furnished according to an FDA-approved indication.
Article | May/June 2019
Article | January/February 2019
News | 10.17.18
Cardiac Dimensions' Carillon System Gains Reimbursement Approval in Germany
October 18, 2018—Cardiac Dimensions, Inc. announced that InEK, the German Institute for the Hospital Remuneration System, has granted a permanent diagnosis-related group (DRG) code covering reimbursement for the company’s Carillon mitral contour system to treat patients with functional mitral regurgitation (FMR) in Germany.
Article | September/October 2018
News | 08.01.18
Boston Scientific Closes Claret Medical Acquisition and Receives CMS Reimbursement Designation
August 2, 2018—Boston Scientific Corporation announced that it has closed its acquisition of Claret Medical, Inc., which has developed and commercialized the Sentinel cerebral embolic protection system to protect patients from the risk of stroke in transcatheter aortic valve replacement procedures.